Stoke Therapeutics (STOK) Net Margin (2022 - 2026)
Stoke Therapeutics' quarterly Net Margin came in at 802.75% in Q1 2026, down 87393.0% year-on-year from N/an in Q1 2025, and up 80.54% quarter-over-quarter from 4124.39% in Q4 2025.
Stoke Therapeutics has reported Net Margin for 5 years, with the latest figure at 802.75% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 87393.0% year-over-year to 802.75%; the trailing twelve-month figure through Mar 2026 stood at 528.86% (down 55508.0% YoY), and the FY2025 full-year result was 3.71%, up 23904.0% from the prior year.
- Net Margin for Q1 2026 stood at 802.75%, up from 4124.39% in the prior quarter.
- The five-year high for Net Margin was 71.19% in Q1 2025, with the low at 4124.39% in Q4 2025.
- Average Net Margin over 5 years is 811.03%, with a median of 743.14% recorded in 2023.
- Year-over-year, Net Margin jumped 91632 bps in 2024 and slumped 407715 bps in 2025.
- Tracing STOK's Net Margin over 5 years: stood at 786.32% in 2022, then declined by 23 bps to 963.56% in 2023, then soared by 95 bps to 47.24% in 2024, then plunged by 8631 bps to 4124.39% in 2025, then jumped by 81 bps to 802.75% in 2026.
- The last three Net Margin figures came in at 802.75% (Q1 2026), 4124.39% (Q4 2025), and 360.68% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | -802.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -802.75% |
| Dec 31, 2025 | -4,124.39% |
| Sep 30, 2025 | -360.68% |
| Jun 30, 2025 | -169.96% |
| Mar 31, 2025 | 71.19% |
| Dec 31, 2024 | -47.24% |
| Sep 30, 2024 | -540.05% |
| Jun 30, 2024 | -531.88% |
| Mar 31, 2024 | -625.57% |
| Dec 31, 2023 | -963.56% |
| Sep 30, 2023 | -743.14% |
| Jun 30, 2023 | -1,237.20% |
| Mar 31, 2023 | -438.41% |
| Dec 31, 2022 | -786.32% |
| Sep 30, 2022 | -900.28% |
| Jun 30, 2022 | -764.28% |
| Mar 31, 2022 | -823.03% |